Search by Medical Condition

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Clinical Trials for Atherosclerosis

• Safety and Efficacy of Urinary Kallidinogenase for Large Artery Atherosclerosis Acute Ischemic Stroke
• The Effect of Early Administration of PCSK9 Inhibitor to Acute Ischemic Stroke Patients Associated With Atherosclerosis on the Stroke Prognosis and Lipid Profile
• Extra Alirocumab in Addition to Statin Therapy in Asymptomatic Intracranial Atherosclerotic Stenosis (EAST-aICAS)
• COlchicine iN Circulating Inflammatory Markers After StrokE (CONCISE)
• Combination of Antiplatelet and Anticoagulation for AIS Patients Witn Concomitant NVAF and Extracranial/Intracranial Artery Stenosis
• YN001 in Healthy Subjects and Patients With Coronary Atherosclerosis
• NAC Treatment and Outcomes in Patients With Advanced Atherosclerosis and DM
• Semaglutide and Vascular Regeneration
• Polygenic Risk-based Detection of Subclinical Coronary Atherosclerosis and Intervention With Statin and Colchicine
• VICTORION-ASCERTAIN: Implementation Study (v-ASCERTAIN)
• The Effects of Allicor on Patients After Revascularization Treatment During a Year
• Effects of aSPIrin Versus Aspirin Plus Low-dose RIvaroxaban on Carotid aTherosclerotic Plaque Inflammation
• Effectiveness and Safety Study of Early add-on of Ezetimibe With Atorvastatin in Very High-risk Patients
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
• Fractional Flow Reserve to Determine Atherosclerosis Renal Hypertension Stenting
• Effect of Tirzepatide on Progression of Coronary Atherosclerosis Using MDCT
• Effects of Pitavastatin or Combination of Pitavastatin and Ezetimibe on Glucose Metabolism Compared to AtoRvastatin in atheroscLerotic Cardiovascular Disease Patients With Metabolic Syndrome: The EZ-PEARL Randomized Trial
• Anticoagulant Using Rivaroxaban on Top of Aspirin Versus Antiplatelet Therapy in Intracranial Atherostenosis Stenosis
• A Study of Olezarsen (ISIS 678354) in Participants With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease, or With Severe Hypertriglyceridemia
• High-Resolution Assessment of Extracranial Plaques in Evolocumab Treatment
• Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction (OCEAN(a)) - Outcomes Trial
• A Phase I Study to Evaluate Safety and Pharmacokinetics of Escalating Single Doses and Multiple Doses of SP-8356
• Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease Events
• Predicting Stroke Risk in ICAD With Novel MRI
• Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
• Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis
• EVALUATION OF LOW DOSE COLCHICINE AND TICAGRELOR IN PREVENTION OF ISCHEMIC STROKE IN PATIENTS WITH STROKE DUE TO ATHEROSCLEROSIS
• Comparing Perclose to Statseal in Conjunction With Perclose in Femoral 6 French Arteriotomy Closure
• Effect of Liraglutide on Subclinical Atherosclerosis in Patients With Type 1 Diabetes Mellitus
• The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE)
• A Study of VERVE-101 in Patients With Familial Hypercholesterolemia and Cardiovascular Disease
• Atmeg (Atorvastatin and Omega-3 Combination) and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
• Choline Fenofibrate and Carotid Atherosclerosis in Patients With Type 2 Diabetes and Combined Dyslipidemia
• A Study of Olezarsen (Formerly Known as AKCEA-APOCIII-LRx) in Adults With Hypertriglyceridemia and Atherosclerotic Cardiovascular Disease (Established or at Increased Risk for), and/or With Severe Hypertriglyceridemia
• Colchicine in Decrease of Perivascular Inflammation Index on Coronary CTA: A Randomized Open-label Trial
• A Study for Exploring the Efficacy of Naoxintong Capsules in the Treatment of Coronary Atherosclerotic Plaque on the Basis of Optimal Medical Therapy (Aspirin,Statins,Clopidogrel, Etc.): Stage One
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease
• Statins and prOgression of Coronary atheRosclerosis in melanomA Patients Treated With chEckpoint inhibitorS
• Effect of Fimasartan on Extended RAS and Vascular Functions in Patients With Type 2 Diabetes and Hypertension
• Direct Mechanical Thrombectomy Versus Bridging Therapy
• Semaglutide Anti-Atherosclerotic Mechanisms of Action Study in Type 2 Diabetes Patients
• Effect of Hyperthyroidism and Its Treatment in Graves' Disease to Early Marker of Atherosclerosis
• A Comparative Study of Indobufen and Aspirin in Patients With Coronary Atherosclerosis
• A Research Study Looking at the Effect of Food Intake on How the Medicine NN0385-0434 Behaves in the Body of Healthy Participants
• Effect Of Semaglutide In Coronary Atheroma Plaque
• 68Ga-FAPI PET/MR for Atherosclerosis
• PericOronary INflammaTion in Non-Obstructive Coronary Artery Disease
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease
• A Research Study Looking at How the Medicine NNC0385-0434 Works in the Body of Healthy Japanese Men
• Trial of PCSK9 Inhibition in Patients With Acute Stroke and Symptomatic Intracranial Atherosclerosis
• A Research Study Looking at How NNC0385-0434 Tablets Work to Lower Blood Cholesterol in People With Heart Disease or a High Risk of Heart Disease
• DES and Medical Treatment for ICAD Trial
• A Randomized Study to Evaluate the Effect of an "Inclisiran First" Implementation Strategy Compared to Usual Care in Patients With Atherosclerotic Cardiovascular Disease and Elevated LDL-C Despite Receiving Maximally Tolerated Statin Therapy (VICTOR
• Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease
• Study in Primary Care Evaluating Inclisiran Delivery Implementation + Enhanced Support
• Low Dose ColchicinE in pAtients With Peripheral Artery DiseasE to Address Residual Vascular Risk
• Air Pollution (PM2.5) on Accelerated Atherosclerosis: A Montelukast Interventional Study in Modernizing China
• Study of 68GaNOTA-Anti-MMR-VHH2 in Oncological Lesions and Cardiovascular Atherosclerosis.
• Anti-inflammatory Effects of Simvastatin
• Effects of Ezetimibe Combination Therapy for Patients With Atherosclerotic Cardiovascular Disease; Randomized Comparison of LDL-cholesterol Targeting <70 Versus <55mg/dL; Ez-PAVE Trial
• Treatment of Patients With Atherosclerotic Disease With Methotrexate-associated to LDL Like Nanoparticles
• Reducing Intracranial atheroSclErosis With Repatha
• Reducing Intracranial atheroSclErosis With Repatha
• PET Detection of CCR2 in Human Atherosclerosis
• A Pragmatic Randomized Trial of Icosapent Ethyl for High-Cardiovascular Risk Adults
• Clinical Transfer of a Vulnerable Atherosclerotic Plaque Tracer : 99mTc-cAbVCAM1-5 (ATHENA)
• Study on Prevention and Treatment of Atherosclerotic Cerebral Occlusive Disease With Remote Ischemic Conditioning
• Oral Colchicine in Argentina to Prevent Restenosis
• Effect of Sarilumab on Atherosclerotic Disease Assessed by PET/CET in Patients With RA (SARIPET)
• Impact of PCSK9 Inhibitors on Coronary Microvascular Dysfunction in Patients With Atherosclerotic Cardiovascular Disease Proved by Myocardial Ischemia and Needing Coronarography
• Study of Urinary Kallikrein to Enhance Collateral Circulation in Symptomatic Intracranial Atherosclerosis
• Cysteinyl Leukotriene Antagonist in Atherosclerosis Inhibition in Patients After Endovascular Treatment Due to Peripheral Arterial Disease
• How Atorvastatin Affects the Gut Flora and Metabolomics?
• Canadian Study of Arterial Inflammation in Patients With Diabetes and Vascular Events: EvaluatioN of Colchicine
• PsA T2T Statin Trial on Carotid and Coronary Atherosclerosis
• Ertugliflozin: Cardioprotective Effects on Epicardial Fat
• Anti-Inflammatory Drug and Endothelial Function
• Treatment of Patients With Atherosclerotic Disease With Paclitaxel-associated to LDL Like Nanoparticles
• Functional Improvement of Coronary Artery Narrowing by Cholesterol Reduction With a PCSK9 Antibody
• A SAD/MAD Study of Safety, Tolerability and Pharmacologic Activity of BT200 in Normal Volunteers
• Effect of Atorvastatin on Subclinical Atherosclerosis
• The CHORAL Flow Study
• Discontinuation of Postmenopausal Hormone Therapy: Impact on the Cardiovascular System and Quality of Life
• 68Ga-DOTATATE PET-CTA Imaging for the Early Detection of Progressing Coronary Atherosclerosis
• Nitrite Effects on Cardiac Muscle in CABG
• How Does Antiretroviral Therapy Affect Coronary Atherosclerosis: A Serial CT Study
• 11C-PIB PET Study in MESA at Columbia University
• Effect of Evolocumab on Saphenous Vein Graft Patency Following Coronary Artery Bypass Surgery
• The Effects of Evolocumab in Patients With Diabetes and Atherosclerotic Vascular Disease
• Type 2 Diabetic Patients Maintained on Statin Therapy
• Study to Evaluate the Effects of MEDI6012 on Apolipoprotein B100 Metabolism
• The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques
• A Randomized Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Cardiovascular Disease
• Management of Cardiovascular Disease in Kidney Disease (MaCK) Study
• Effect of Evolocumab on Vascular Function
• Thyroid Hormone Replacement for Subclinical Hypothyroidism and Dyslipidemia in ASCVD (ThyroHeart-Lipid Study)
• SYNergy Stent® System Implantation With Mandatory Intra-VascularUltra-Sound Guidance to Examine the Safety of Cessation of Dual Anti-Platelet Therapy in High Bleeding Risk Patients at One Month
• Effects of a Dipeptidyl Peptidase-4 Inhibitor Sitagliptininsulin on the Progression of Coronary Atherosclerosis in Patients With Type 2 Diabetes
• Rosuvastatin/Ezetimibe Versus Rosuvastatin in ASCVD Patients With Type 2 DM
• Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Add-On
• The Alirocumab for Stopping Atherosclerosis Progression in Saphenous Vein Grafts (ASAP-SVG) Pilot Trial
• Angiotensin-II Receptor Antibodies Blockade With Losartan in Patients With Lupus Nephritis
• PCSK9 Inhibition in Patients With Symptomatic Intracranial Atherosclerosis
• Coronary Atherosclerosis T1-Weighted Characterization (CATCH)
• High-intensity Rosuvastatin and Moderate-intensity Rosuvastatin/Ezetimibe in ASCVD Patients
• Coronary Angiography THerapeutic Virtual Reality
• Clinical Trial of Efficacy and Safety of Divaza for Adjustment of Oxidative Disorders in Patients With Cerebral Atherosclerosis
• High-Dose Statin Combined With Telmisartan vs Amlodipine on Glucose Metabolism in ASCVD Patients With IFG and Hypertension
• Study of Intracoronary CD34+ Cell Administration in Patients With Early Coronary Atherosclerosis
• Effectiveness of Butylphthalide on Dynamic Cerebral Autoregulation in Patients With Acute Ischemic Stroke.
• High-intensity Rosuvastatin vs. Moderate-intensity Rosuvastatin/Ezetimibe in High Atherosclerotic Cardiovascular Disease Risk Patients With Type 2 Diabetes
• Efficacy of Maraviroc in Modulating Atherosclerosis in HIV Patients.
• Inclisiran for Subjects With ASCVD or ASCVD-Risk Equivalents and Elevated Low-density Lipoprotein Cholesterol
• Inclisiran for Participants With Atherosclerotic Cardiovascular Disease and Elevated Low-density Lipoprotein Cholesterol
• Preventive Arterial Wall Phenotype and Low-dose Fluvastatin/Valsartan Combination
• The Effect of Prednisone on Atherogenesis as Studied in the Macrophage Foam Cell Formation Model System.
• Investigating the Lowest Threshold of Vascular Benefits From LDL Cholesterol Lowering in Patients With Stable CV Disease
• Using Ultrasonography, Shear Wave Elastography, Strain Imaging, and 3-D Volume Ultrasonography on Cardiovascular Disease
• IMaging Della PLAcca Carotidea
• Stroke Minimization Through Additive Anti-atherosclerotic Agents in Routine Treatment
• Sonodynamic Therapy on Patients With Femoropopliteal PAD and Claudication
• 18F-Flutemetamol and Plaque Vulnerability
• PPG Project 3 - PET/MRI of the Brain-hematopoiesis-atherosclerosis Axis in PTSD Patients
• Frequent, Low-Dose Erythropoietin A Mechanistic Approach to Mitigate Adverse Cardiovascular Effects of Erythropoietin
• INvestigating the Lowest Threshold of Vascular bENefits From LDL Lowering With a PCSK9 InhibiTor in healthY Volunteers
• Effect of Cilostazol on Carotid Atherosclerosis Estimated by 3D Ultrasound in Patients With Type 2 Diabetes
• Rosuvastatin Effect on Atherosclerotic Plaque Metabolism
• the Efficacy and Safety of Indobufen and Low-dose Aspirin in Different Regimens of Antiplatelet Therapy
• Subclinical Cardiovascular Disease in Psoriatic Disease
• P2Y12 Inhibitor Monotherapy Versus Extended DAPT in Patients Treated With Bioresorbable Scaffold
• The Estrogen Replacement and Atherosclerosis Trial ; Primary Outcome Measure is Mean Minimal Coronary Artery Diameter After Avg of 3.2 Yrs.
• Impact of Evolocumab on the Effects of Clopidogrel in Patients With High On-Treatment Platelet Reactivity
• Treatment Targets for Inflamed Intracranial Atherosclerosis on Vessel Wall MRI
• Assessment of the Long-Term Safety and Efficacy of Bempedoic Acid (CLEAR Harmony OLE)
• RANGER™ Paclitaxel Coated Balloon vs Standard Balloon Angioplasty
• An Extension Trial of Inclisiran Compared to Evolocumab in Participants With Cardiovascular Disease and High Cholesterol
• Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women
• Alirocumab and Reverse Cholesterol Transport
• Effect of Pioglitazone on Insulin Resistance, Atherosclerosis Progression and Clinical Course of Coronary Heart Disease
• Multiple Ascending Doses of MEDI6012 in Subjects With Stable Atherosclerotic Cardiovascular Disease
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) as Add-on to Ezetimibe Therapy in Patients With Elevated LDL-C (CLEAR Tranquility)
• Targeted PET/CT and PET/MRI Imaging of Vascular Inflammation
• Assessment of Atherosclerotic Plaque Characteristics Change by DCE-MRI With Alirocumab
• Evaluation of Long-Term Efficacy of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia at High Cardiovascular Risk
• Evaluation of the Efficacy and Safety of Bempedoic Acid (ETC-1002) in Patients With Hyperlipidemia and Statin Intolerant
• The Effect of Anacetrapib on Vascular Function and Arterial Stiffness
• Effect of Vascepa on Improving Coronary Atherosclerosis in People With High Triglycerides Taking Statin Therapy
• Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes
• Does Sildenafil Improve Endothelial Dysfunction in Rheumatoid Arthritis?
• The TRUST Trial - CardioVascular Imaging ECHO
• The TRUST Study - CardioVascular Imaging IMT
• Effect of Statins on Trained Immunity
• Study to Evaluate the Effect of Nicotinamide Riboside on Immunity
• Stress-MRI Assessment After Right Coronary Artery CTO Recanalization
• Coronary Artery Disease Progression in Patients With Prediabetes
• The Efficacy and Safety of Combined Therapy With Red Yeast Rice and Low-dose Statin：Comparing With Standardized Statin
• Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-term
• Angioplasty and Stenting for Patients With Symptomatic Intracranial Atherosclerosis
• Evaluation of Long-Term Safety and Tolerability of ETC-1002 in High-Risk Patients With Hyperlipidemia and High CV Risk (CLEAR Harmony)
• Effect of Sitagliptin on Progression of Coronary Intermediate Lesion
• Oxidative Stress and Oxysterols Profiling in Patients With Carotid Revascularization
• The Effect of Ticagrelor on 15-Epi-Lipoxin A4 and Inflammation
• Inflammatory Pathogenesis of Coronary Atherosclerosis in HIV
• Effects on Re-endothelialisation With Bydureon Treatment in Type 2 Diabetes Subjects
• Trial to Evaluate the Effect of ALN-PCSSC Treatment on Low Density Lipoprotein Cholesterol (LDL-C)
• Intensive Rosuvastatin Therapy on Cerebral Hemodynamics in Patients With Atherosclerotic Intracranial Arterial Stenosis
• Sitagliptin Effects on Arterial Vasculature and Inflammation in Obesity
• Cardiovascular Inflammation Reduction Trial - Inflammation Imaging Study
• Efficacy and Safety of Simvastatin-ezetimibe Combination Therapy Among Patients With SLE
• A phase3 Study Measuring the Effect of Rosuvastatin 20 mg on Carotid Intima-Media Thickness in Chinese Subjects With Subclinical Atherosclerosis
• Effect of Low-dose vs. High-dose Pitavastatin on In-stent Restenosis
• A Study to Evaluate the Efficacy and Safety of Rosuvastatin in the Treatment of the Carotid Atherosclerotic Plaques
• TIcagrelor in Rotational Atherectomy to Reduce TROPonin Enhancement
• Study to Assess the Efficacy and Safety of CLBS12 in Patients With Critical Limb Ischemia (CLI)
• PET Imaging of Natriuretic Peptide Receptor C (NPR-C) in Carotid Atherosclerosis (Volunteer - BioD and Safety Study)
• CER-001 Atherosclerosis Regression ACS Trial
• Intensive Statin Treatment in Acute Ischemic Stroke Patients With INtracranial Atherosclerosis
• Different Doses of Rosuvastatin Therapy on Regression of Critical Coronary Atherosclerosis in ACS Patients
• Effects of Lomitapide on Carotid and Aortic Atherosclerosis
• Proof of Mechanism Study of MLN1202 on Atherosclerotic Inflammation in Participants With Stable Atherosclerotic Cardiovascular Disease
• Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium
• Efficacy Study of Olmesartan Medoxomil on Coronary Atherosclerosis and Epicardial Adipose Tissue(EAT)
• PET/CT Imaging Companion Study To ACTG A5314
• Pharmacogenomics of Antiplatelet Response
• Mineralocorticoid Receptor Antagonism Clinical Evaluation in Atherosclerosis Trial
• Effect of Bydureon on Carotid Atherosclerosis Progression in Type 2 Diabetes Mellitus
• Colchicine in Vascular Inflammation Assessed With PET Imaging
• Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis (MARINA)
• Multicenter, Prospective, Randomized, Controlled, Double-blind Trial on the Impact of Rosuvastatin on Subclinical Markers of Atherosclerosis in Patients With Primary Necrotizing Vasculitides
• Accelerated Atherosclerosis in High Risk Population Groups: An Assessment by Magnetic Resonance Imaging
• Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
• Effect of Darapladib on Cantharidin-Induced Inflammatory Blisters in Subjects With Type 2 Diabetes Mellitus (T2DM)
• Intracoronary Infusion of Mononuclear Cells Autologous Bone Marrow in Patients With Chronic Coronary Occlusion and Ventricular Dysfunction, Previously Revascularized.
• Darapladib China PK
• A Single Ascending Dose Study Investigating the Safety, Pharmacokinetics and Pharmacodynamics of RO6836191 in Healthy Male Volunteers.
• Effects Vitamin D Suppletion on Postprandial Leukocyte Activation
• ROsuvastatin LOading and Clinical Outcomes Trial
• Phase II Randomized Placebo-controlled Study With Vitamin K2 in Asymptomatic Calcified Carotid Stenosis
• Effects of REnal Denervation for Resistant Hypertension on Exercise Diastolic Function and Regression of Atherosclerosis and the Evaluation of NEW Methods Predicting A successfuL Renal Sympathetic Denervation (RENEWAL-EXERCISE, -REGRESS, and -PREDIC
• Study to Determine the Effect of 14 Days Dosing With Darapladib (SB-480848) on Carotid Plague Composition in Patients With Planned Carotid Endarterectomy
• Vitamin D to Improve Endothelial Function in SLE
• Molecular Imaging of Plaque Vulnerability
• Indocyanine Green Fluorescence Uptake in Human Carotid Artery Plaque
• Pharmacokinetic Interaction of Darapladib and CYP 3A4 in Healthy Subjects
• Effects of Sitagliptin on Endothelial Function in Type 2 Diabetes on Background Metformin Therapy
• Study to Determine the Effect of Repeated Administration of Diltiazem on the Pharmacokinetics of Darapladib (Sb-480848).
• Effects of L-thyroxine Replacement on Serum Lipid and Atherosclerosis in Hypothyroidism
• Effect of L-Thyroxine on Lipid Profiles and Atherosclerosis in Subclinical Hypothyroidism
• Does Rosuvastatin Delay Progression of Atherosclerosis in HIV
• The Prediction of Extent and Risk Profile of Coronary Atherosclerosis and Their Changes During Lipid-lowering Therapy Based on Non-invasive Techniques
• To Estimate the Potential Effects of Repeat Doses of Darapladib on the Pharmacokinetics (PK) of Rosuvastatin as Well as Evaluating Safety and Tolerability in Healthy Volunteers
• A Study to Assess the Effect of SB 659032 on Platelet Function
• SB-659032 Platelet Aggregation Study
• Study of Anti-atherosclerotic Activity of Inflaminat in Asymptomatic Participants With Subclinical Atherosclerosis
• Study of Anti-atherosclerotic Activity of Karinat in Postmenopausal Women
• Study of Anti-atherosclerotic and Estrogen-like Activity of Karinat in Perimenopausal Women
• Atherosclerosis Monitoring and Atherogenicity Reduction Study
• A Study to Assess the Pharmacokinetics, Safety and Tolerability of Repeat Oral Doses of Darapladib (SB-480848) in Subjects With Severe Renal Impairment
• Beneficial Effects of Grape Seed Proanthocyanidin Extrat on Progression of Atherosclerotic Plaques in Clinical Use
• Physical and Chemical Study of Atherosclerosis Mechanisms
• ER Niacin/Laropiprant Impact on Cardiovascular Markers and Atheroprogression in HIV-infected Individuals on cART
• Fluvastatin AmelIorates aTHerosclerosis Study
• Proof of Concept Study of BMS-823778 to Assess the Effects on Atherosclerosis
• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab
• A Proof of Concept Study to Determine the Local Delivery and Efficacy of Nanocort
• Revacept in Symptomatic Carotid Stenosis
• Erythrocyte-bound Apolipoprotein B After Withdrawal of Statin Therapy
• Effects of ROFLUMILAST on Subclinical Atherosclerosis in Chronic Obstructive Pulmonary Disease (COPD)
• Effects of Vildagliptin/Metformin Combination on Markers of Atherosclerosis, Thrombosis, and Inflammation in Diabetics With Coronary Artery Disease
• Silencing Inflammatory Activity by Injecting Nanocort in Patients at Risk for Atherosclerotic Disease
• Effect of Mipomersen on LDL-Cholesterol Levels in Patients Treated by Regular Apheresis
• Assessment of the Role of the Growth Hormone (GH) Onthe Intestinal Triglyceride-rich-lipoproteins (TRL) Metabolism
• Effect of ACP-501 on Safety, Tolerability, Pharmacokinetics and Pharmacodynamics in Subjects With Coronary Artery Disease
• Saxagliptin and Atherosclerosis
• Impact of Sarpogrelate in the Function of Endothelial Progenitor Cells
• Effect of Aged Garlic Extract on Atherosclerosis
• Pharmacokinetics & Safety Study of Clopidogrel 75mg and Aspirin 100mg Coadministration
• Aliskiren Effect on Aortic Plaque Progression
• The Effect of Vitamin A on Atherosclerosis
• Rosuvastatin Effect on Reducing Coronary Atherosclerosis Plaques Volume
• Effect of Molsidomine on the Endothelial (Internal Layer of Blood Vessels) Dysfunction in Patients With Angina Pectoris
• Cardiovascular Risk Assessment in Patients With Severe Psoriasis Treated With Biologic Agents
• Gastric Bypass Versus Best Medical Treatment on Progression of Carotid-intima Media Thickness in Type 2 Diabetes Mellitus (T2DM)
• Impact of Dabigatran and Phenprocoumon on Clopidogrel Mediated ADP Induced Platelet Aggregation in Patients With Atrial Fibrillation
• The Effect of Atorvastatin and Pioglitazone on Carotid Atherosclerosis With the Use of Positron Emission Tomography-computed Tomography (PET-CT)
• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events)
• Biologically Modified Saphenous Vein Transplants for Improved CABG Outcomes
• Trial of Ateronon in Patients With Coronary Disease to Evaluate Its Effectiveness in Assessing the Risk Factors of Atherosclerosis
• A Study to Evaluate the Safety, Tolerability, and Activity of Intravenous MLDL1278A in Patients on Standard-of-Care Therapy for Stable Atherosclerotic Cardiovascular Disease (GLACIER)
• Assessment With CCTA and MRI in Asymptomatic Patients With Type 2 Diabetes for Detection of Unrecognized Myocardial Scar in Subclinical Coronary Atherosclerosis
• REVEAL: Randomized EValuation of the Effects of Anacetrapib Through Lipid-modification
• Type 2 Diabetes Mellitus and Atherosclerosis
• The Effect(s) of Sevelamer Carbonate (Renvela) on Atherosclerotic Plaque Inflammation Judged by FDG-PET Scan
• Comprehensive Evaluation of Ischemic Heart Disease Using MRI
• Evaluation of The Effects of Nebivolol in Comparison to Atenolol on Wall Shear Stress and Rupture Prone Coronary Plaques
• Effect of Intensive Blood Pressure Control on Progression of Coronary Atherosclerosis: Randomized Evaluation by Intravascular Ultrasound
• Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Endothelial Function
• Effect of Extended-Release Niacin on Saphenous Vein Graft Atherosclerosis
• Randomized Trial of Imaging Versus Risk Factor-Based Therapy for Plaque Regression
• Effect of Intensive Lipid Lowering Treatment Compared to Moderate Lipid Lowering Treatment on Carotid Intima-media Thickness (CIMT)
• Effect of CER-001 on Atherosclerosis in Acute Coronary Syndrome (ACS) Patients - Efficacy and Safety: The CHI SQUARE Trial
• Carotid Plaque Characteristics by MRI in AIM-HIGH (Carotid MRI Substudy)
• A Trial of Rosuvastatin in Systemic Lupus Erythematosus
• Blood Markers for Inflammation and Coronary Artery Vasoreactivity Testing in Patients With Chest Pain and Normal Coronary Arteries
• Novel Pathways to Manage Inflammation and Atherosclerosis in Dialysis Patients: Role of Nicotinic Acid
• A Clinical Trial Comparing Cangrelor to Clopidogrel Standard Therapy in Subjects Who Require Percutaneous Coronary Intervention (PCI) (CHAMPION PHOENIX)
• Study to Evaluate Darapladib in Moderately Hepatically Impaired Subjects
• Drug-Eluting Stents vs. Bare Metal Stents In Saphenous Vein Graft Angioplasty
• Effect of Enhanced External Counterpulsation (EECP) on Subclinical Atherosclerosis
• Study to Evaluate Subclinical Atherosclerosis (an Early Sign of Heart Disease) in Healthy Adult Immigrant Asian Indians
• Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE)
• Safety Study of BMS-844421 for Treatment of Hypercholesterolemia
• Lipoprotein-associated Phospholipase A2 (Lp-PLA2) Progenitor Cells and Coronary Atherosclerosis in Humans
• The Effect of Tekturna on Endothelial Function and Endothelial Progenitor Cells in Patients With Early Atherosclerosis
• Clinical Trial for Dose Finding and Safety of RVX000222 in Subjects With Stable Coronary Artery Disease
• Ramipril 10 mg/Day Prevention
• AFRICA: Atorvastatin Plus Fenofibric Acid (TriLipix) in the Reduction of Intermediate Coronary Atherosclerosis
• Revascularization of Renal Artery Stenosis Versus Medical Therapy for the Treatment of Ischemic Nephropathy
• Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients
• Safety & Effectiveness on Vascular Structure and Function of ACZ885 in Atherosclerosis and Either T2DM or IGT Patients
• A Multicenter Randomized Parallel-group Study to Investigate the Efficacy of a Combination of Rosuvastatin and Fenofibrate in the Patients With Diabetes or Atherosclerotic Vascular Diseases With Metabolic Syndrome
• Statin Therapy to Improve Atherosclerosis in HIV Patients
• The Study of the Effects of Vitamin A on Immune System in Patients With Atherosclerosis
• Effect of Atorvastatin on Vascular Inflammation in Type 2 Diabetes
• Effects on Atherosclerosis Regression of Ezetimibe or Ezetimibe Plus Simvastatin; Evaluated by Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
• Anti-inflammatory Effect of Atorvastatin in Atherosclerotic Plaques Assessed by FDG-PET Imaging
• Rosuvastatin Evaluation of Atherosclerotic Chinese Patients (REACH)
• Plaque Inflammation and Dysfunctional HDL in AIM-HIGH
• Pentoxifylline and Combination Antiretroviral Therapy to Improve Blood Vessel Function in HIV-Infected People
• Resistance to Antithrombotic Therapy
• Heme Oxygenase (HO) Activity and Adenosine Induced Vasodilation
• Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease Patients
• A Trial of the Safety and Efficacy of K-604 for the Treatment of Atherosclerosis
• Is Augmentation of PORH by Rosuvastatin Adenosine-receptor Mediated?
• Multiple-Dose Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of BMS-779788 in Healthy Subjects
• Study of Cilostazol and Probucol Alone and in Combination on Atherosclerosis Related Biomarker---atherosclerosis Cerebral Infarction Patient as Study Subject
• Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker
• Local Paclitaxel Delivery for SFA Disease
• Aggressive Medical Treatment Evaluation for Asymptomatic Carotid Artery Stenosis
• Merck Carotid Atherosclerosis Trial (MK-0000-111)(COMPLETED)
• The Stabilization of Atherosclerotic Plaque by Initiation of Darapladib Therapy Trial
• Evaluating the Effectiveness of Pentoxifylline at Improving Blood Vessel Function in HIV-infected People Not Receiving Antiretroviral Medications
• Exploratory Study of Coronary Flow Reserve Measurements, a Non-Invasive Method for Coronary Function Measurements
• The Clopidogrel and Aspirin After Surgery for Coronary Artery Disease
• Safety, Pharmacokinetic Study of RVX000222 in Healthy Subjects and Subjects With Low HDL Cholesterol
• Persantin Preceding Elective PCI
• Platelet Hyperreactivity to Aspirin and Stroke
• Inflammation and Vascular Function in Atherosclerosis
• Inflammation and Vascular Function in Atherosclerosis
• A Healthy Volunteer Pharmacokinetic Study of Single and Repeat Doses of SB-480848
• Early Detection of Atherosclerosis: a Randomized Trial in the Primary Prevention of Cardiovascular Diseases.
• A Phase II Clinical Study of SB-480848 in Dyslipidemic Patients
• Aliskiren's Effect on Arterial Stiffness and Platelet Function in Patients With Diabetes Mellitus (DM)
• Effect of Atorvastatin and Lifestyle Intervention on Progression of Pre-Clinical Atherosclerosis
• Carotid Atherosclerosis: MEtformin for Insulin ResistAnce Study
• Anti-Inflammatory Effects of Pioglitazone
• Evaluate Carotid Artery Plaque Composition by Magnetic Resonance Imaging in People Receiving Cholesterol Medication
• Double-Blind, Randomized, Placebo-Controlled Trial of MLN1202 on C-Reactive Protein Levels in Patients With Risk Factors for Cardiovascular Disease
• Effects of Nicotinic Acid Plus Simvastatin Versus Simvastatin Alone on Carotid and Femoral Intima-Media Thickness in Patients With Peripheral Artery Disease (NASCIT)
• A Study With Darapladib to Collect Tolerability Information
• Evaluate the Utility of 18FDG-PET as a Tool to Quantify Atherosclerotic Plaque (MK-0000-081 AM3)(COMPLETED)
• Change in Plaque Characteristics With Atorvastatin
• An Imaging Study in Patients With Atherosclerosis Taking Rilapladib or Placebo for 12 Weeks
• Efficacy and Safety of Stent Implantation in Symptomatic Extra- and Intracranial Artery Stenosis
• Effects of Crestor on Inflammation of Atherosclerotic Plaques
• Intravenous Versus Intracoronary Use of Abciximab
• Trial to Assess the Safety and Effects of Vorapaxar in Japanese Subjects With Acute Coronary Syndrome (P04772; MK-5348-016)
• Contrast-enhanced Ultrasound (CE-US) and Magnetic Resonance Imaging (MRI): Evaluating Plaque Neovascularisation
• Effectiveness of Rosuvastatin at Preventing the Progression of Atherosclerosis in HIV Positive Patients
• The Copenhagen Insulin and Metformin Therapy Trial
• Ezetimibe Plus Simvastatin Versus Simvastatin in Untreated Subjects With High Cholesterol (P03435)
• Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With High Cholesterol (P03434)
• Compare the Safety & Efficacy of Rosuvastatin 40mg in Combination With Ezetimibe 10mg
• Ezetimibe Plus Atorvastatin Versus Atorvastatin Alone in Subjects With Primary Hypercholesterolemia (Study P03406)
• Effect of Ezetimibe Plus Simvastatin on Flow-Mediated Brachial Artery Vasoactivity in Subjects With Primary Hypercholesterolemia (Study P03336)
• Switching to Rosuvastatin Versus Adding Ezetimibe to Atorvastatin Versus Doubling the Dose of Atorvastatin in Patients With Hypercholesterolemia and Risk Factors (P03708)
• Comparison of Co-administration of Ezetimibe Plus Simvastatin Versus Simvastatin Alone in Primary Hypercholesterolemia (P03476)
• Assessment of Potential Interaction Between Ezetimibe and Rosuvastatin in Healthy Subjects With High Cholesterol (P03317)
• Ezetimibe Plus Simvastatin Versus Simvastatin in Patients With Hypercholesterolemia and Coronary Risk Factors (P03405)
• Ezetimibe Plus Atorvastatin Versus Atorvastatin in Untreated Subjects With Primary Hypercholesterolemia and Coronary Heart Disease (P03396)
• Ezetimibe Plus Simvastatin Versus Simvastatin Alone in African-American Subjects With Primary Hypercholesterolemia (P03377)
• Effect of Short Term Atorvastatin Treatment,80mg/Day on Early Regression of Carotid Artery Atherosclerotic Lesions
• Diagnosis and Therapy of Vulnerable Atherosclerotic Plaque
• A Study to Evaluate the Effects of 3 Months Dosing With GW856553, as Assessed FDG-PET/CT Imaging
• Phase I Study of SB-480848(Darapladib) -Repeat Dose Study in Healthy Japanese Male Subjects-
• CRESTOR Athero Imaging Head to Head IVUS Study
• Trial to Assess the Ocular Safety of Vorapaxar (SCH 530348) in Participants With Atherosclerosis (Study P05183)
• Vascular Endothelial Protection Effects of Dextromethorphan
• Effect of Pioglitazone on Insulin Resistance and Atherosclerosis in Renal Allograft Recipients Without Diabetes
• Evaluation of Atorvastatin on Atherosclerosis Composition
• A Study to Evaluate Whether Correction of Anemia Using Recombinant Human Erythropoietin Reduces the Progression of Atherosclerosis and Cardiac Hypertrophy in Pre-dialysis Chronic Kidney Disease Patients
• Vascular Effects of Ezetimibe/Simvastatin and Simvastatin on Atherosclerosis
• Effect of Ezetimibe Plus Simvastatin Versus Simvastatin Alone on Atherosclerosis in the Carotid Artery (ENHANCE)(P02578)
• A Study Investigating the Concentrations of Darapladib in Blood and the Safety of This Compound in Healthy Japanese Men
• A Study Investigating Blood Concentrations Of Rosuvastatin When Co-administered With GW856553 In Healthy Men
• PET Imaging of Peripheral Benzodiazepine Receptors in Patients With Carotid Atherosclerosis
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Particpants With Acute Coronary Syndrome (TRA•CER) (Study P04736)
• Trial to Assess the Effects of Vorapaxar (SCH 530348; MK-5348) in Preventing Heart Attack and Stroke in Patients With Atherosclerosis (TRA 2°P - TIMI 50) (P04737)
• 12-week Open-label, Phase IIIb Comparing Efficacy and Safety of Rosuvastatin (CRESTOR™) in Combination With Ezetimibe
• A Study to Examine the Effect of Particle Size on Bioequivalence and Bioavailability
• Targeting Peroxisome Proliferator-activated Receptor-gamma in Peritoneal Dialysis Patients - Will it Reduce Inflammation, Atherosclerosis, Calcification and Improve Survival of Peritoneal Dialysis Patients?
• Effects of Ezetimibe Add-On to Statin Therapy on Adipokine Production in Obese and Metabolic Syndrome Patients With Atherosclerosis
• Atorvastatin Treatment to Attenuate the Progression of Cardiovascular Disease in Hemodialysis Patients
• Evaluation of Chylomicrons Metabolism in Sub-Clinical Atherosclerosis in Patients Whit Heterozigous Familial Hypercholesterolemia (FH) Treated With Statin Plus Ezetimibe
• The Effect of a Natural Polyphenolic Extract From Pomegrnate (POMX) on the Development of Atherosclerosis in Diabetic Patients
• Comparison Of Two Tablet Formulations Of SB-568859
• Effect of Androgel on Atherogenesis in Type 2 Diabetic Males With Hypogonadotrophic Hypogonadism
• Effect of 5 Years of GH Replacement on Atherosclerosis
• Imaging of Totally Blocked Arteries
• Does a Seven Day Treatment With Dipyridamole Induce Protection Against Ischemia-Reperfusion Injury?
• PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease
• Atheroma Reduction With Chloroquine in Patients With the Metabolic Syndrome (ARCH-MS)
• Chloroquine to Treat People With Metabolic Syndrome Aim2 (ARCH-MS)
• The Effect of Licorice Root Extract and Pomegranate Juice on Atherosclerotic Parameters in Diabetic Patients
• The Effect of MK 0633 in Patients With Atherosclerosis (0633-008)(COMPLETED)
• Rilonacept to Improve Artery Function in Patients With Atherosclerosis
• Study Of The Effects Of SB 480848 (Darapladib) On The Electrical Conduction Of The Heart
• Comparative Study of the Effect of Ezetimibe Versus Extended-Release Niacin on Atherosclerosis
• Effect Of Rilapladib (SB-659032) On Platelet Aggregation
• Cangrelor Versus Standard Therapy to Achieve Optimal Management of Platelet Inhibition.
• A Randomized, Double Blind Study To Compare The Effects Of Olmesartan Medoxomil Versus Placebo In Patients With Established Atherosclerosis
• PIoglitazone for PrEvention of Restenosis in Diabetic Patients
• Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus
• Cortisone or Drug Eluting Stents (DES) as Compared to Bare Metal Stents (BMS) to EliminAte Restenosis
• Effects Of Atorvastatin On Macrophage Activity And Plaque Inflammation Using Magnetic Resonance Imaging
• A Study To Determine The Effect Of SB-480848 On Asthma
• Systemic Immunomodulatory Effects and Pharmacogenetics of Atorvastatin in Early Atherosclerosis
• Study Effect of VIA-2291 on Atherosclerotic Vascular Inflammation in Patients Undergoing Elective Carotid Endarterectomy
• Salsalate Therapy to Reduce Insulin Resistance and Cardiovascular Risk
• Omacor for the Treatment of Vascular Dysfunction in Patients With Type 2 Diabetes Mellitus
• Intensive Glycemic Control and Skeletal Health Study
• Study Comparing Effect On Carotid Atherosclerosis Following Conversion From Tacrolimus To Sirolimus Post-Transplant In Kidney Transplant Patients
• Carotid Atherosclerosis Regression at Magnetic Resonance Assessment.
• Azelnidipine Anti-Coronary Atherosclerotic Trial in Hypertensive Patients by Serial Volumetric IVUS Analysis(ALPS-J)
• Testosterone Replacement in Older Men and Atherosclerosis Progression
• Aspirin Dose and Atherosclerosis in Patients With Heart Disease
• Aspirin Dose and Atherosclerosis in Patients With Metabolic Syndrome
• SB-480848 In Subjects With Coronary Heart Disease
• Integrated Biomarker And Imaging Study - 2
• The Effects of Acetylcysteine on Alleviating Damage of Oxidative Stress in Hemodialysis Patients
• Effects of Mycophenolate Mofetil (MMF) on Surrogate Markers for Cardiovascular Disease in HIV-1 Infected Patients
• Diet, Exercise, Niacin, and Fenofibrate to Reduce Heart Disease Risk Factors in Individuals With HIV Lipodystrophy or Dyslipidemia
• Early Therapeutic Effects of Statins and Fibrates on Unstable Atherosclerotic Plaques
• Serp-1 for the Treatment of Acute Coronary Syndrome
• Reducing Total Cardiovascular Risk in an Urban Community
• Oxford Niaspan Study: Effects of Niaspan on Atherosclerosis and Endothelial Function
• Trial of Clopidogrel After Surgery for Coronary Artery Disease (CASCADE Trial)
• Atherosclerosis Underlying Development Assessed by Intima-Media Thickness in Patients on Rimonabant
• Aspirin for the Prevention of Recurrent Venous Thromboembolism
• Aspirin Non-responsiveness and Clopidogrel Endpoint Trial.
• Homocysteine Lowering and Atherosclerosis Reduction Trial (HART)
• Effect of Valsartan on Carotid Artery Disease
• Olmesartan Medoxomil in Atherosclerosis
• Efficacy and Safety of Pactimibe in Patients With Atherosclerosis
• Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Coronary Artery Disease
• Vein-Coronary Atherosclerosis And Rosiglitazone After Bypass Surgery: The VICTORY Trial
• The Impact of Rosiglitazone on Regression of Atherosclerosis
• EASEGO Study: Doubling of Atorvastatin/Simvastatin or INEGY in Patients With Hypercholesterolemia and Coronary Artery Disease(CAD)(0653A-089)
• Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant Patients
• Efficacy and Safety of the ACAT Inhibitor CS-505 (Pactimibe) for Reducing the Progression of Carotid Artery Disease. This Study is Also Known as CAPTIVATE.
• High-Density Lipoprotein (HDL) Modulation and Endothelial Function
• Stop Atherosclerosis in Native Diabetics Study
• Rosiglitazone (Avandia®) Treatment in HIV: Its Effect on Blood Vessels
• The Study of Atherosclerosis With Ramipril and Rosiglitazone
• Claudication: Exercise Versus Endoluminal Revascularization (CLEVER)
• Trial of Cilostazol in Symptomatic Intracranial Arterial Stenosis II
• High-Density Lipoprotein (HDL) Cholesterol Increased Plaque Stabilization in the Elderly
• STRADIVARIUS (Strategy To Reduce Atherosclerosis Development InVolving Administration of Rimonabant - the Intravascular Ultrasound Study)
• Hexadecasaccharide (SR123781A) in Patients With Unstable Angina or Non-ST-Segment Elevation Myocardial Infarction
• Lupus Atherosclerosis Prevention Study
• The Effect of Fasudil on Vascular Function in Humans
• Niacin Plus Statin to Prevent Vascular Events
• Tea's Effect on Atherosclerosis Pilot Study (TEA Study)
• MARS - Monitored Atherosclerosis Regression Study
• Rosiglitazone Versus a Sulfonylurea On Progression Of Atherosclerosis In Patients With Heart Disease And Type 2 Diabetes
• TART - Troglitazone Atherosclerosis Regression Trial
• Rho Kinase in Patients With Atherosclerosis
• The Effects of Atorvastatin in Patients With Atherosclerosis
• The Contribution of Endothelin to Vasomotor Function in Diseased Coronary Arteries
• EPAT: Estrogen in the Prevention of Atherosclerosis Trial
• ELITE: Early Versus Late Intervention Trial With Estradiol
• Detection of Plaque Inflammation by Positron Emission Tomography (PET)-Effects of Simvastatin on Plaque Inflammation
• Rosuvastatin Affecting Aortic Valve Endothelium
• BVAIT: B-Vitamin Atherosclerosis Intervention Trial
• VEAPS: Vitamin E Atherosclerosis Prevention Study
• Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) Trial
• Benefits of Medical Therapy Plus Stenting for Renal Atherosclerotic Lesions
• Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL
• ARISE - Aggressive Reduction of Inflammation Stops Events
• Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE)
• A Blinded Study Conducted at Multiple Centers Evaluating Various Doses of an Investigational Agent (BO-653) Against Placebo, for Safety and Effectiveness in Preventing Post-Angioplasty Blood Vessel Re-Closure (Restenosis) in Stented Vessels.
• Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE)
• Stop Atherosclerosis in Native Diabetics Study
• Effect of High Dose Vitamin E on Carotid Atherosclerosis
• Effects of Angiotensin-Converting Enzyme Inhibitor (Ramipril) Therapy on Blood Vessel Inflammation
• Effects of Hormone Replacement Therapy on Inflammation and Stiffening of Artery Walls
• Aspirin Or Warfarin To Prevent Stroke
• Effects of Hormone Therapy on the Immune Systems of Postmenopausal Women With Chronic Infections
• The Role of Angiotensin Type I Receptor in the Regulation of Human Coronary Vascular Function
• The Role of Angiotensin Type I Receptor in the Regulation of Human Peripheral Vascular Function
• Action to Control Cardiovascular Risk in Diabetes (ACCORD)
• Vitamin E and C to Slow Progression of Common Carotid Artery Plaque Build-Up
• Cholesterol-Lowering Atherosclerosis Study (CLAS)
• Familial Atherosclerosis Treatment Study
• Cholesterol Reduction in Seniors Program (CRISP)